Genetically mimicked effects of ASGR1 inhibitors on all-cause mortality and health outcomes: a drug-target Mendelian randomization study and a phenome-wide association study

BACKGROUND: Asialoglycoprotein receptor 1 (ASGR1) is emerging as a potential drug target to reduce low-density lipoprotein (LDL)-cholesterol and coronary artery disease (CAD) risk. Here, we investigated genetically mimicked ASGR1 inhibitors on all-cause mortality and any possible adverse effects. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guoyi, Schooling, C. Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318778/
https://www.ncbi.nlm.nih.gov/pubmed/37400795
http://dx.doi.org/10.1186/s12916-023-02903-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318778/
https://www.ncbi.nlm.nih.gov/pubmed/37400795
http://dx.doi.org/10.1186/s12916-023-02903-w

Ejemplares similares